Last reviewed · How we verify
tingling — Treatment Landscape & Competitive Intelligence
2 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Neurotox | CESIUM | BioActive Nutritional, Inc. | Acetylcholine Release Inhibitor [EPC] | |||
| Neurotox | GADOLINIUM | BioActive Nutritional, Inc. | Acetylcholine Release Inhibitor [EPC] |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- BioActive Nutritional, Inc. · 2 drugs in tingling
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in tingling:
- tingling treatment updates — RSS
- tingling treatment updates — Atom
- tingling treatment updates — JSON
Cite this brief
Drug Landscape (2026). tingling — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/tingling. Accessed 2026-06-10.
Related
- tingling full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing